SFDA: National Biotechnology Strategy Highlights Saudi Leadership in Medical Innovation
Technology tamfitronics SFDA: National Biotechnology Strategy Highlights Saudi Leadership in Medical InnovationThe Saudi Food and Drug Authority (SFDA) stated that Saudi National Biotechnology Strategy positions the Kingdom as a global pioneer in biomanufacturing and medical innovation, reported the Saudi Press Agency (SPA).SFDAs Chief Executive Officer, Dr Hisham bin Saad Al-Jadhey, has commended the strategy for its central focus on critical areas such as vaccines, biolocalization, genomics, and plant improvement.During his speech on the 4th annual international conference of the Saudi Society of Clinical Pharmacy (SSCP), Al-Jadhey reviewed SFDAs continuous efforts to fully achieve the national strategy, as follows:Establishing a strong framework of regulations and guidelines for biotechnologySigning clinical trial protocols for biopharmaceuticalsPromoting Manufacturing standards for bioproductsFostering Clinical evaluation and assessment of bioproductsSupporting research, development and manufacturing of bioproductsProviding post-market safety monitoring of bioproductsTechnology tamfitronics...